Lux Capital has 22 tracked deals to U.S. Venture Partners's 23. Stage focus, check size, and sector fit compared side by side.
Lux Capital is a venture capital with 22 tracked deals. U.S. Venture Partners is an active investor with 23 tracked deals. U.S. Venture Partners shows 1 more tracked round than Lux Capital in this dataset, which is the clearest signal of deployment pace between the two. Sector focus diverges: Lux Capital concentrates on Aerospace Defense, Artificial Intelligence and Biotech and U.S. Venture Partners on generalist deals. Recent tracked names include Amca and Atrandi Biosciences for Lux Capital and Adaptive6 and Apono for U.S. Venture Partners.
Investors like Lux Capital · Investors like U.S. Venture Partners · Lux Capital co-investors · Full investor directory